The Brazilian Ministry of Health signed an agreement last week (4 July) with the pharmaceutical company Abbott Laboratories to reduce the price of its HIV/AIDS drug Kaletra by 29.5 per cent.
You are here: Home / Health & Medical News / AIDS/HIV / Abbott Drops Price of HIV/AIDS Drug Kaletra in Brazil
Leave a Reply